FDA Recalls Olympia Mineral Blend Injectable for Lack of Sterility Assurance
Olympia Compounding Pharmacy recalls 6,113 vials of Olympia Mineral Blend injectable due to lack of assurance of sterility. The product was distributed nationwide; patients should not use it and should consult their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall addresses a theoretical risk of sterility failure in an injectable product without any reported illnesses, injuries, or hospitalizations, meeting the rubric criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Olympia Compounding Pharmacy is recalling Olympia Mineral Blend (Magnesium Chloride 80 mg/mL, Zinc Sulfate 1 mg/mL, Manganese Sulfate 20 mcg/mL, Copper Gluconate 0.2 mg/mL, and Sodium Selenite 18 mcg/mL) in 30 mL multi-dose vials. Approximately 6,113 vials are affected by this recall.
The product is being recalled due to lack of assurance of sterility. The affected lots include L24B1 with beyond-use date of 6/16/2022, L24D16 with beyond-use date of 6/16/2022, A24C24-22, and A24E24-22 with beyond-use date of 7/24/2022. This injectable product has been distributed nationwide in the USA, Puerto Rico, and US Virgin Islands.
Patients who have been administered this product should not use it and should contact their healthcare provider for guidance on alternative treatments. Healthcare providers should discontinue use of affected lots and consult with Olympia Compounding Pharmacy or their patient care team regarding appropriate follow-up.
The recalled product
- Product
- Olympia Mineral Blend Magnesium Chloride 80 mg/mL Zinc Sulfate 1 mg/mL Manganese Sulfate 20 mcg/mL Copper Gluconate 0.2 mg/mL Sodium Selenite 18 mcg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0061-30.
- Affected units
- 6,113
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots: L24B1 BUD: 6/16/2022
- L24D16 BUDL 6/16/2022
- A24C24-22
- A24E24-22 BUDL 7/24/2022
Distribution
Part of a larger recall action
This product is one of 53 recalled by Olympia Compounding Pharmacy dba Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 53 products in this recall →Related recalls
Same manufacturer · Olympia Compounding Pharmacy dba Olympia Pharmacy
See all →- HighLidocaine 2% injectable solution recalled for lack of sterility assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Compounded Papaverine Injection Due to Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Testosterone Cypionate Injection Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighCompounded pharmaceutical vials recalled due to sterility assurance failure
FDA (Drugs) · 2022-06-01
- HighOndansetron Hydrochloride vials recalled due to sterility assurance concerns
FDA (Drugs) · 2022-06-01
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22